Longhorn Vaccines and Diagnostics, LLC: FDA filings under this applicant name
FDA lists 0 510(k) clearances under the applicant name “Longhorn Vaccines and Diagnostics, LLC”, plus 1 De Novo decision, across 1 product code in 1 review panel. Related companies, subsidiaries and acquired businesses that file under other applicant names are counted on their own pages, not here.
Top product codes
| Product code | Device | Submissions | 510(k) clearances |
|---|---|---|---|
| QBD | Microbial Nucleic Acid Storage And Stabilization Device | 1 | 0 |
Review panels
- Microbiology (1)
PMA and De Novo decisions
| Number | Pathway | Device | Decision date |
|---|---|---|---|
| DEN170029 | De Novo | Microbial Nucleic Acid Storage And Stabilization Device | 2018-03-19 |
Recalls
openFDA lists no recalls under a recalling firm named Longhorn Vaccines and Diagnostics, LLC.
Recalling firms are matched to this applicant name by name only (same normalization), so related entities that recall under another name are not counted. A recall count says nothing about how safe one company's devices are compared with another's.
Frequently asked questions
How many FDA 510(k) clearances are listed under Longhorn Vaccines and Diagnostics, LLC?
FDA lists 0 510(k) clearances under the applicant name “Longhorn Vaccines and Diagnostics, LLC”, plus 1 De Novo decision, across 1 product code in 1 review panel. Filings under other applicant names, such as subsidiaries, are not included.
Which FDA product codes appear under Longhorn Vaccines and Diagnostics, LLC?
The most frequent FDA product codes under this applicant name are QBD (Microbial Nucleic Acid Storage And Stabilization Device, 1).
Next steps
- See all 0 Longhorn Vaccines and Diagnostics, LLC clearances with predicates and recalls
- Run predicate analysis for product code QBD, Longhorn Vaccines and Diagnostics, LLC's most frequent
Data from openFDA (510(k), PMA, De Novo, device recalls), ClinicalTrials.gov and SEC company tickers. Each page covers one FDA applicant name, with punctuation and legal suffixes removed; filings under other names are not included. Review days run from FDA receipt to decision. Not regulatory advice. Report an error in this data.